Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine TAP block versus ropivacaine for analgesia in laparoscopic colorectal cancer surgery
ChiCTR2400083108Phase 4Recruiting
- Sponsor
- Tianjin People's Hospital
- Start
- Apr 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of liposomal bupivacaine and ropivacaine in postoperative pain (2 arms), sponsored by Tianjin People's Hospital. Primary endpoints: Cumulative opioid consumption after surgery, Pain intensity by VAS and 6 more. Started Apr 2024; status: recruiting.
02
Drugs
liposomal bupivacaineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400083108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083108.